Lyme disease vaccine 70 percent effective: Pfizer
•A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial.
•If approved by regulators, it would be the only vaccine for humans against Lyme disease.
•“Lyme disease can cause potentially serious consequences – where individuals and families face…
هذا الخبر من The Hill - US Politics. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the only vaccine for humans against Lyme disease. “Lyme disease can cause potentially serious consequences – where individuals and families face…المصدر: The Hill - US Politics | Source: The Hill - US Politics
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة The Hill - US Politics. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by The Hill - US Politics. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
